gamma-aminobutyric acid has been researched along with Pain, Breakthrough in 2 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the analgesic effect of pregabalin combined with intrathecal sufentanil infusion for the treatment of breakthrough pain in patients with bone metastases." | 9.19 | [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. ( Cao, Q; Gu, S; Huang, D; Wu, L; Xu, H, 2014) |
| "A total of 60 breakthrough pain patients with bone metastases were randomly divided to 3 groups: group A (pregabalin combined with intrathecal sufentanil infusion group, n=20), group B (placebo combined with intrathecal sufentanil infusion group, n=20) and group C (oral morphine sulfate controlled-release tablet group, n=20)." | 9.19 | [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. ( Cao, Q; Gu, S; Huang, D; Wu, L; Xu, H, 2014) |
| "Pregabalin combined with intrathecal sufentanil infusion can effectively relieve breakthrough pain in patients with bone metastases." | 9.19 | [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. ( Cao, Q; Gu, S; Huang, D; Wu, L; Xu, H, 2014) |
| "To evaluate the analgesic effect of pregabalin combined with intrathecal sufentanil infusion for the treatment of breakthrough pain in patients with bone metastases." | 6.79 | [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. ( Cao, Q; Gu, S; Huang, D; Wu, L; Xu, H, 2014) |
| "A total of 60 breakthrough pain patients with bone metastases were randomly divided to 3 groups: group A (pregabalin combined with intrathecal sufentanil infusion group, n=20), group B (placebo combined with intrathecal sufentanil infusion group, n=20) and group C (oral morphine sulfate controlled-release tablet group, n=20)." | 6.79 | [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. ( Cao, Q; Gu, S; Huang, D; Wu, L; Xu, H, 2014) |
| "Pregabalin combined with intrathecal sufentanil infusion can effectively relieve breakthrough pain in patients with bone metastases." | 6.79 | [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. ( Cao, Q; Gu, S; Huang, D; Wu, L; Xu, H, 2014) |
| "To evaluate the analgesic effect of pregabalin combined with intrathecal sufentanil infusion for the treatment of breakthrough pain in patients with bone metastases." | 5.19 | [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. ( Cao, Q; Gu, S; Huang, D; Wu, L; Xu, H, 2014) |
| "A total of 60 breakthrough pain patients with bone metastases were randomly divided to 3 groups: group A (pregabalin combined with intrathecal sufentanil infusion group, n=20), group B (placebo combined with intrathecal sufentanil infusion group, n=20) and group C (oral morphine sulfate controlled-release tablet group, n=20)." | 5.19 | [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. ( Cao, Q; Gu, S; Huang, D; Wu, L; Xu, H, 2014) |
| "Pregabalin combined with intrathecal sufentanil infusion can effectively relieve breakthrough pain in patients with bone metastases." | 5.19 | [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. ( Cao, Q; Gu, S; Huang, D; Wu, L; Xu, H, 2014) |
| "To evaluate the analgesic effect of pregabalin combined with intrathecal sufentanil infusion for the treatment of breakthrough pain in patients with bone metastases." | 2.79 | [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. ( Cao, Q; Gu, S; Huang, D; Wu, L; Xu, H, 2014) |
| "A total of 60 breakthrough pain patients with bone metastases were randomly divided to 3 groups: group A (pregabalin combined with intrathecal sufentanil infusion group, n=20), group B (placebo combined with intrathecal sufentanil infusion group, n=20) and group C (oral morphine sulfate controlled-release tablet group, n=20)." | 2.79 | [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. ( Cao, Q; Gu, S; Huang, D; Wu, L; Xu, H, 2014) |
| "Pregabalin combined with intrathecal sufentanil infusion can effectively relieve breakthrough pain in patients with bone metastases." | 2.79 | [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. ( Cao, Q; Gu, S; Huang, D; Wu, L; Xu, H, 2014) |
| "Opioid-induced hyperalgesia has recently been described as representing a challenge for physicians in the clinical setting." | 2.50 | Managing difficult pain conditions in the cancer patient. ( Mercadante, S, 2014) |
| "Whereas most pain due to cancer can be relieved with relatively simple methods using oral analgesics, as suggested by WHO guidelines, some patients may have difficult pain situations that require more complex approaches." | 2.50 | Managing difficult pain conditions in the cancer patient. ( Mercadante, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mercadante, S | 1 |
| Cao, Q | 1 |
| Huang, D | 1 |
| Xu, H | 1 |
| Wu, L | 1 |
| Gu, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pain Phenotyping of Patients With Bone Cancer Pain[NCT03908853] | 70 participants (Anticipated) | Observational | 2019-02-05 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for gamma-aminobutyric acid and Pain, Breakthrough
| Article | Year |
|---|---|
Managing difficult pain conditions in the cancer patient.
Topics: Amines; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Breakthrough Pain; Cyclohexanec | 2014 |
1 trial available for gamma-aminobutyric acid and Pain, Breakthrough
| Article | Year |
|---|---|
[Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases].
Topics: Analgesics, Opioid; Bone Neoplasms; Breakthrough Pain; gamma-Aminobutyric Acid; Humans; Injections, | 2014 |